HER2 transmembrane domain mutation: comprehensive characteristics and real-world evidence of treatment response in Chinese lung adenocarcinoma

BACKGROUND: HER2 transmembrane domain (TMD) mutation has been reported as a rare driver mutation associated with advanced stage disease and a poor prognosis in patients with lung adenocarcinoma (LUAD). We aimed to comprehensively profile the genetic landscape and treatment response information of HE...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Ziqi, Xing, Jiahua, Li, Ji, Wang, Weiwei, Wang, Yadong, Song, Yang, Yang, Xiaoying, Xue, Jianchao, Ye, Junyi, Li, Bing, Han-Zhang, Han, Zhao, Jiaxing, Zhang, Xiaochun, Peng, Feng, Chen, Fengxia, Chen, Xueqin, Lu, Yan, Ying, Shenpeng, Wu, Dongping, Zhang, Xinwei, Ma, Caixia, Lai, Lipeng, Ma, Songling, Liang, Dianjing, Liu, Peng, Li, Xiaoguang, Liang, Naixin, Li, Shanqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044484/
https://www.ncbi.nlm.nih.gov/pubmed/33889517
http://dx.doi.org/10.21037/tlcr-21-107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044484/
https://www.ncbi.nlm.nih.gov/pubmed/33889517
http://dx.doi.org/10.21037/tlcr-21-107

Ejemplares similares